Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine

作者: Sara Tomczyk , Ruth Lynfield , William Schaffner , Arthur Reingold , Lisa Miller

DOI: 10.1093/CID/CIW067

关键词:

摘要: … We assessed the impact of PCV13 on antibiotic-nonsusceptible IPD rates. … as pneumococcal isolation from a normally sterile site in a resident from 10 US surveillance sites. Antibiotic-…

参考文章(28)
STEVEN B. BLACK, HENRY R. SHINEFIELD, STELLA LING, JOHN HANSEN, BRUCE FIREMAN, DAVID SPRING, JACK NOYES, EDWIN LEWIS, PAULA RAY, JANELLE LEE, JILL HACKELL, Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatric Infectious Disease Journal. ,vol. 21, pp. 810- 815 ,(2002) , 10.1097/00006454-200209000-00005
S. A. Madhi, L. Kuwanda, C. Cutland, K. P. Klugman, The Impact of a 9-Valent Pneumococcal Conjugate Vaccine on the Public Health Burden of Pneumonia in HIV-Infected and -Uninfected Children Clinical Infectious Diseases. ,vol. 40, pp. 1511- 1518 ,(2005) , 10.1086/429828
Marie R. Griffin, Yuwei Zhu, Matthew R. Moore, Cynthia G. Whitney, Carlos G. Grijalva, U.S. Hospitalizations for Pneumonia after a Decade of Pneumococcal Vaccination The New England Journal of Medicine. ,vol. 369, pp. 155- 163 ,(2013) , 10.1056/NEJMOA1209165
L. A. Hicks, M. G. Bartoces, R. M. Roberts, K. J. Suda, R. J. Hunkler, T. H. Taylor, S. J. Schrag, US Outpatient Antibiotic Prescribing Variation According to Geography, Patient Population, and Provider Specialty in 2011 Clinical Infectious Diseases. ,vol. 60, pp. 1308- 1316 ,(2015) , 10.1093/CID/CIV076
Katherine L O'Brien, Lara J Wolfson, James P Watt, Emily Henkle, Maria Deloria-Knoll, Natalie McCall, Ellen Lee, Kim Mulholland, Orin S Levine, Thomas Cherian, Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates The Lancet. ,vol. 374, pp. 893- 902 ,(2009) , 10.1016/S0140-6736(09)61204-6
Bernard W. Beall, Robert E. Gertz, Rachel L. Hulkower, Cynthia G. Whitney, Matthew R. Moore, Angela B. Brueggemann, Shifting Genetic Structure of Invasive Serotype 19A Pneumococci in the United States The Journal of Infectious Diseases. ,vol. 203, pp. 1360- 1368 ,(2011) , 10.1093/INFDIS/JIR052
FT Cutts, SMA Zaman, G ym Enwere, S Jaffar, OS Levine, JB Okoko, C Oluwalana, A Vaughan, SK Obaro, A Leach, KP McAdam, E Biney, M Saaka, U Onwuchekwa, F Yallop, NF Pierce, BM Greenwood, RA Adegbola, None, Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial The Lancet. ,vol. 365, pp. 1139- 1146 ,(2005) , 10.1016/S0140-6736(05)71876-6
In H. Park, Matthew R. Moore, John J. Treanor, Stephen I. Pelton, Tamara Pilishvili, Bernard Beall, Mark A. Shelly, Barbara E. Mahon, Moon H. Nahm, , Differential Effects of Pneumococcal Vaccines against Serotypes 6A and 6C The Journal of Infectious Diseases. ,vol. 198, pp. 1818- 1822 ,(2008) , 10.1086/593339
L. A. Hicks, Y.-W. Chien, T. H. Taylor, M. Haber, K. P. Klugman, , Outpatient Antibiotic Prescribing and Nonsusceptible Streptococcus pneumoniae in the United States, 1996–2003 Clinical Infectious Diseases. ,vol. 53, pp. 631- 639 ,(2011) , 10.1093/CID/CIR443
Lauri A. Hicks, Dominique L. Monnet, Rebecca M. Roberts, Increase in Pneumococcus Macrolide Resistance, USA Emerging Infectious Diseases. ,vol. 16, pp. 896- 897 ,(2010) , 10.3201/EID1605.091424